Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion

Nat Commun. 2019 Aug 6;10(1):3505. doi: 10.1038/s41467-019-11569-z.

¹ Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
² IFOM-IEO Campus, European Institute of Oncology, Milan, 20139, Italy.
³ School of Biological Science, University of Reading, Reading, RG6 6LA, UK.
⁴ MTATTK Lendület Cancer Biomarker Research Group, 2nd Department of Pediatrics, Semmelweis University, Budapest, H-1117, Hungary.
⁵ MTA-SE Pediatrics and Nephrology Research Group, 2nd Department of Pediatrics, Semmelweis University, Budapest, H-1117, Hungary.
⁶ ECMC, Charing Cross Hospital, London, W120nn, UK.
⁷ Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende (CS), 87036, Italy.
⁸ Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK. l.magnani@imperial.ac.uk.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.